The Guanylyl Cyclase Inhibition by MB as Vasoplegic Circulatory Shock Therapeutical Target
Journal:
Current Drug Targets
Volume:
7
Page:
1195-1204
Author(s):
P.R. B. Evora and F. Viaro
Evolution of Antipsychotic Intervention in the Schizophrenic Psychosis
Journal:
Current Drug Targets
Volume:
7
Page:
1205-1215
Author(s):
David L. Garver
Nutritional Control, Gene Regulation, and Transformation of Vascular Smooth Muscle Cells in Atherosclerosis
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
6
Page:
151-168
Author(s):
A. Linares, S. Perales, R. J. Palomino-Morales, M. Castillo and M. J. Alejandre
Phosphodiesterase 5 Inhibitors - Drug Design and Differentiation Based on Selectivity, Pharmacokinetic and Efficacy Profiles
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3459-3465
Author(s):
Claudiu T. Supuran, Antonio Mastrolorenzo, Giuseppe Barbaro and Andrea Scozzafava
Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3467-3484
Author(s):
Antonio Aversa, Roberto Bruzziches, Marcello Pili and Giovanni Spera
Cardiovascular Effects of Phosphodiesterase 5 Inhibitors
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3485-3494
Author(s):
Thorsten Reffelmann and Robert A. Kloner
Possible Therapies of Septic Shock: Based on Animal Studies and Clinical Trials
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3535-3541
Author(s):
C. C. Wu
Therapeutic Use of Nitric Oxide Scavengers in Shock and Sepsis
Journal:
Current Pharmaceutical Design
Volume:
12
Page:
3543-3549
Author(s):
Brian G. Harbrecht
Molecular Methods for Individualization of Psychotropic Drug Treatment
Journal:
Current Pharmacogenomics
Volume:
4
Page:
177-189
Author(s):
B. Bondy and P. Zill
Essential Hypertension: Translating Pathophysiology into Pharmacogenomics
Journal:
Current Pharmacogenomics
Volume:
4
Page:
219-229
Author(s):
F. Filigheddu, G. Argiolas, C. Troffa and N. Glorioso